Connor Page
patient
Connor Page was a 39-year-old father diagnosed with pancreatic cancer in 2022, whose participation in a clinical trial for the drug daraxonrasib provided him with several months of improved health and valuable time with his family before his passing in 2024.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Connor Page learned he had pancreatic cancer in 2022 and participated in a Phase 1 trial.
6
Andre Bourbeau
George Zogopoulos
Jennifer Knox
Mark Johnson
Dana Johnson
Daniel Renouf
Jen Lovrics
Michelle Capobianco
The Globe and Mail: Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patients